Mita Puspita

发表

Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine

J. Yang, J. Excler, I. Rengganis, 2019, PloS one.

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2–11 years: a phase II preliminary report

J. Yang, S. Hadinegoro, H. I. Satari, 2020, BMC Pediatrics.

One-month follow up of a randomized clinical trial-phase II study in 6-<24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine.

J. Yang, S. Hadinegoro, H. I. Satari, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.